“Conjunctivitis in Tralokinumab-Treated Adult Patients with Moderate-To-Severe Atopic Dermatitis: Pooled Results from Five Clinical Trials”, J of Skin, vol. 5, no. 1, p. s10, Jan. 2021, doi: 10.25251/skin.5.supp.10.